UK Law Lets Sponsors Conduct Trials Without Fear of Patent Reprisal

Clinical Trials Advisor
Sponsors of novel drug therapies can evaluate their candidates against competing products in the UK without the threat of litigation, thanks to amended patent law that took effect Oct. 2.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00